{
    "medicine_id": "1b43fd29e2ca92907dabff2fc9562ce5c012da82",
    "platform_id": "DB12808",
    "metadata": {
        "name": "Aklief 50 mcg Cream",
        "composition": "50 mcg Trifarotene",
        "clinical_particulars": {
            "therapeutic_indications": "Trifarotene is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older L9013",
            "contraindications": {
                "disease": "Trifarotene does not appear to carry any risk of carcinogenesis when used at standard doses L9013 Systemic exposures in mice following both topical and oral administration were up to 1642 times higher than those seen in humans at the maximal recommended human dose and these systemic concentrations did not result in observed carcinogenicity Data regarding overdosage of trifarotene is unavailable",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Trifarotene exerts its effects via agonism at retinoid receptors these receptors function to alter DNA transcription resulting in downstream modulation of the expression of various genes involved in acne pathogenesis A187081 It may be associated with skin irritation and should not be applied to cuts abrasions or otherwise damaged skin As trifarotene may result in photosensitivity patients should be cautioned to avoid excess sun exposure and to use sunscreen and or protective clothing if exposure is unavoidable L9013",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}